Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity
- 2 December 2004
- Vol. 23 (20) , 2614-2622
- https://doi.org/10.1016/j.vaccine.2004.11.028
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004
- Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activitiesEuropean Journal of Immunology, 2003
- Oral Pretreatment of Mice with CpG DNA Reduces Susceptibility to Oral or Intraperitoneal Challenge with VirulentListeria monocytogenesInfection and Immunity, 2003
- Rational design of new CpG oligonucleotides that combine B cell activation with high IFN‐α induction in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2003
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Effect of chemical modifications of cytosine and guanine in a cpg-motif of oligonucleotides: structure–immunostimulatory activity relationshipsBioorganic & Medicinal Chemistry, 2001
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- Stimulation ofin vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotidesMolecular Biology Reports, 1993
- Antitumor Activity of Synthetic Oligonucleotides with Sequences from cDNA Encoding Proteins of Mycobacterium bovis BCGJapanese Journal of Cancer Research, 1992